Eclipse Surgical TMR Laser Shipments Commence Following FDA Approval
This article was originally published in The Gray Sheet
Executive Summary
Shipments of Eclipse Surgical Technologies' Eclipse 2000 transmyocardial revascularization laser system began "immediately" following FDA approval, announced Feb. 11, at a price of $295,000 each, according to the firm.